Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity (Q28278166)
scientific article published on March 29, 2010
Language:
(P31) (Q13442814)
(P304) 1116-27
(P407) (Q1860)
(P433) 6
(P478) 103
(P577) +2010-06-00T00:00:00Z
Monday, March 29, 2010
(P921) (Q63279445)
(Q215118)
(Q419345)
(P953) http://www.thieme-connect.de/products/ejournals/pdf/10.1160/TH09-11-0758.pdf
(P1433) (Q15724413)
(P1476) "Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity" (language: en)
"Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity" (language: en)
(P2093) Joanne van Ryn
Joachim Stangier
Sebastian Haertter
Karl-Heinz Liesenfeld
Wolfgang Wienen
Martin Feuring
Andreas Clemens
(P13046) (Q7318358)
other details
description scientific article published on March 29, 2010

External Links